Perforated peptic ulcer

Kjetil Søreide, Kenneth Thorsen, Ewen M. Harrison, Juliane Bingener, Morten H. Møller, Michael Ohene-Yeboah, Jon Arne Søreide

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Perforated peptic ulcer is a common emergency condition worldwide, with associated mortality rates of up to 30%. A scarcity of high-quality studies about the condition limits the knowledge base for clinical decision making, but a few published randomised trials are available. Although Helicobacter pylori and use of non-steroidal anti-inflammatory drugs are common causes, demographic differences in age, sex, perforation location, and underlying causes exist between countries, and mortality rates also vary. Clinical prediction rules are used, but accuracy varies with study population. Early surgery, either by laparoscopic or open repair, and proper sepsis management are essential for good outcome. Selected patients can be managed non-operatively or with novel endoscopic approaches, but validation of such methods in trials is needed. Quality of care, sepsis care bundles, and postoperative monitoring need further assessment. Adequate trials with low risk of bias are urgently needed to provide better evidence. We summarise the evidence for perforated peptic ulcer management and identify directions for future clinical research.

Original languageEnglish (US)
Pages (from-to)1288-1298
Number of pages11
JournalThe Lancet
Volume386
Issue number10000
DOIs
StatePublished - Sep 26 2015

Fingerprint

Peptic Ulcer
Sepsis
Patient Care Bundles
Knowledge Bases
Needs Assessment
Decision Support Techniques
Mortality
Quality of Health Care
Helicobacter pylori
Laparoscopy
Emergencies
Anti-Inflammatory Agents
Demography
Research
Pharmaceutical Preparations
Population
Direction compound
Clinical Decision-Making

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Søreide, K., Thorsen, K., Harrison, E. M., Bingener, J., Møller, M. H., Ohene-Yeboah, M., & Søreide, J. A. (2015). Perforated peptic ulcer. The Lancet, 386(10000), 1288-1298. https://doi.org/10.1016/S0140-6736(15)00276-7

Perforated peptic ulcer. / Søreide, Kjetil; Thorsen, Kenneth; Harrison, Ewen M.; Bingener, Juliane; Møller, Morten H.; Ohene-Yeboah, Michael; Søreide, Jon Arne.

In: The Lancet, Vol. 386, No. 10000, 26.09.2015, p. 1288-1298.

Research output: Contribution to journalArticle

Søreide, K, Thorsen, K, Harrison, EM, Bingener, J, Møller, MH, Ohene-Yeboah, M & Søreide, JA 2015, 'Perforated peptic ulcer', The Lancet, vol. 386, no. 10000, pp. 1288-1298. https://doi.org/10.1016/S0140-6736(15)00276-7
Søreide K, Thorsen K, Harrison EM, Bingener J, Møller MH, Ohene-Yeboah M et al. Perforated peptic ulcer. The Lancet. 2015 Sep 26;386(10000):1288-1298. https://doi.org/10.1016/S0140-6736(15)00276-7
Søreide, Kjetil ; Thorsen, Kenneth ; Harrison, Ewen M. ; Bingener, Juliane ; Møller, Morten H. ; Ohene-Yeboah, Michael ; Søreide, Jon Arne. / Perforated peptic ulcer. In: The Lancet. 2015 ; Vol. 386, No. 10000. pp. 1288-1298.
@article{b55fa61b90484fa8ab2e20336b735b29,
title = "Perforated peptic ulcer",
abstract = "Perforated peptic ulcer is a common emergency condition worldwide, with associated mortality rates of up to 30{\%}. A scarcity of high-quality studies about the condition limits the knowledge base for clinical decision making, but a few published randomised trials are available. Although Helicobacter pylori and use of non-steroidal anti-inflammatory drugs are common causes, demographic differences in age, sex, perforation location, and underlying causes exist between countries, and mortality rates also vary. Clinical prediction rules are used, but accuracy varies with study population. Early surgery, either by laparoscopic or open repair, and proper sepsis management are essential for good outcome. Selected patients can be managed non-operatively or with novel endoscopic approaches, but validation of such methods in trials is needed. Quality of care, sepsis care bundles, and postoperative monitoring need further assessment. Adequate trials with low risk of bias are urgently needed to provide better evidence. We summarise the evidence for perforated peptic ulcer management and identify directions for future clinical research.",
author = "Kjetil S{\o}reide and Kenneth Thorsen and Harrison, {Ewen M.} and Juliane Bingener and M{\o}ller, {Morten H.} and Michael Ohene-Yeboah and S{\o}reide, {Jon Arne}",
year = "2015",
month = "9",
day = "26",
doi = "10.1016/S0140-6736(15)00276-7",
language = "English (US)",
volume = "386",
pages = "1288--1298",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "10000",

}

TY - JOUR

T1 - Perforated peptic ulcer

AU - Søreide, Kjetil

AU - Thorsen, Kenneth

AU - Harrison, Ewen M.

AU - Bingener, Juliane

AU - Møller, Morten H.

AU - Ohene-Yeboah, Michael

AU - Søreide, Jon Arne

PY - 2015/9/26

Y1 - 2015/9/26

N2 - Perforated peptic ulcer is a common emergency condition worldwide, with associated mortality rates of up to 30%. A scarcity of high-quality studies about the condition limits the knowledge base for clinical decision making, but a few published randomised trials are available. Although Helicobacter pylori and use of non-steroidal anti-inflammatory drugs are common causes, demographic differences in age, sex, perforation location, and underlying causes exist between countries, and mortality rates also vary. Clinical prediction rules are used, but accuracy varies with study population. Early surgery, either by laparoscopic or open repair, and proper sepsis management are essential for good outcome. Selected patients can be managed non-operatively or with novel endoscopic approaches, but validation of such methods in trials is needed. Quality of care, sepsis care bundles, and postoperative monitoring need further assessment. Adequate trials with low risk of bias are urgently needed to provide better evidence. We summarise the evidence for perforated peptic ulcer management and identify directions for future clinical research.

AB - Perforated peptic ulcer is a common emergency condition worldwide, with associated mortality rates of up to 30%. A scarcity of high-quality studies about the condition limits the knowledge base for clinical decision making, but a few published randomised trials are available. Although Helicobacter pylori and use of non-steroidal anti-inflammatory drugs are common causes, demographic differences in age, sex, perforation location, and underlying causes exist between countries, and mortality rates also vary. Clinical prediction rules are used, but accuracy varies with study population. Early surgery, either by laparoscopic or open repair, and proper sepsis management are essential for good outcome. Selected patients can be managed non-operatively or with novel endoscopic approaches, but validation of such methods in trials is needed. Quality of care, sepsis care bundles, and postoperative monitoring need further assessment. Adequate trials with low risk of bias are urgently needed to provide better evidence. We summarise the evidence for perforated peptic ulcer management and identify directions for future clinical research.

UR - http://www.scopus.com/inward/record.url?scp=84943416888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943416888&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(15)00276-7

DO - 10.1016/S0140-6736(15)00276-7

M3 - Article

C2 - 26460663

AN - SCOPUS:84943416888

VL - 386

SP - 1288

EP - 1298

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 10000

ER -